The Growing Influence of Precision Medicine and Genomic Profiling in the US Prostate Cancer Market
Precision medicine, driven by genomic profiling and molecular diagnostics, is emerging as a game-changer in prostate cancer management. Through the analysis of genetic mutations and tumor markers, clinicians can design treatment regimens tailored specifically to an individual’s cancer profile. This paradigm shift is redefining the US Prostate cancer Market, as drug development...
0 Comments 0 Shares 412 Views 0 Reviews